Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' offer for the DNA-testing company in a bankruptcy auction. Last month,

The DNA data of more than 15 million customers of DNA testing firm 23andMe is set to be returned to the control of 23andMe co-founder and former CEO Anne Wojcicki, after the non-profit she leads outbid previously announced buyer, biotech Regeneron, by $70 million.

Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, and its trove of genetic data.  | Her $305 million offer topped the previous frontrunner,